Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

The Los Angeles County Department of Public Health received notice from the U.S. Centers for Disease Control and Prevention ...

The CDC has withdrawn $200,000 in annual HIV prevention funding from AVOL Kentucky, a community-based nonprofit. This decision, part of a national funding overhaul, shifts resources away from ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...